Search
Skip to Search Results- 13Inflammatory bowel disease
- 8Colitis
- 5Crohn's disease
- 3Gastrointestinal Tract
- 3Inflammatory Bowel Disease
- 3Microbiome
- 2Gänzle, Michael G.
- 2Koleva, Petya
- 2Valcheva, Rosica
- 1Antunes, L. Caetano M.
- 1Arrieta Mendez, Marie Claire
- 1Beilman, Candace L
- 16Graduate and Postdoctoral Studies (GPS), Faculty of
- 16Graduate and Postdoctoral Studies (GPS), Faculty of/Theses and Dissertations
- 4Agricultural, Food and Nutritional Science, Department of
- 4Agricultural, Food and Nutritional Science, Department of/Journal Articles (Agricultural, Food and Nutritional Science)
-
An Individualized and Multi-faceted Transition Intervention is Needed for Pediatric Patients with Inflammatory Bowel Disease
DownloadFall 2016
The transition of chronically ill patients from pediatric to adult care can be challenging for patients and families and there is no gold standard for how to facilitate this process. An unsuccessful transition has been associated with more negative health outcomes. It is generally agreed upon by...
-
Spring 2012
The aim of this work was to examine any possible IBD activity-related variations in immunoglobulin A (IgA) anti-tissue transglutaminase (tTG) levels in children with IBD. The prevalence of CD in children with IBD was also examined. In a prospective cohort study, children with IBD were screened...
-
Chemically defined diet alters the protective properties of fructo-oligosaccharides and isomalto-oligosaccharides in HLA-B27 transgenic rats
Download2014
Koleva, Petya, Ketabi, Ali, Dieleman, Levinus A., Gänzle, Michael G., Valcheva, Rosica
Non-digestible oligosaccharides (NDO) were shown to reduce inflammation in experimental colitis, but it remains unclear whether microbiota changes mediate their colitis-modulating effects. This study assessed intestinal microbiota and intestinal inflammation after feeding chemically defined...
-
Fall 2016
Anti-TNF therapy is effective for the induction and maintenance of remission in patients with inflammatory bowel disease (IBD). The benefits of anti-TNF therapy include improved quality of life, steroid discontinuation, and reduced hospitalization and surgery rates. Due to their high costs and...
-
Spring 2020
Introduction: Inflammatory bowel disease (IBD), which is consisted of ulcerative colitis (UC) and Crohn’s disease (CD), is a relapsing-remitting inflammatory condition of gastrointestinal tract. Although the exact pathophysiology of IBD is not known yet, it has been suggested that a combination...
-
Spring 2018
Background- Crohn's disease (CD) is a type of inflammatory bowel disease that can cause inflammation throughout the alimentary tract. Many individuals diagnosed with CD ultimately require intestinal resection. Unfortunately, disease often recurs following surgery. The pathophysiology of the...
-
Implementing and Evaluating Virtual Mindfulness-Based Stress Reduction for Adults with Inflammatory Bowel Disease
DownloadFall 2023
Inflammatory bowel diseases (IBD), which include Crohn’s disease and ulcerative colitis, are chronic diseases of the gastrointestinal tract. Individuals living with IBD suffer from chronic symptoms of fatigue and malnutrition and unpredictable flares of acute symptoms including abdominal pain,...
-
Fall 2021
Background & Objective: Periodontitis has been an increasingly common finding in patients who have been diagnosed with Inflammatory Bowel Disease (IBD). Several studies have investigated the association between the two diseases and have confirmed that these two disease entities have a common...
-
Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats
Download2012-01-01
Koleva, Petya, Dieleman, Levinus, Sun, Xu, Gänzle, Michael G., Valcheva, Rosica
Modulation of intestinal microbiota by non-digestible carbohydrates may reduce inflammation in inflammatory bowel disease (IBD). The aim of the present study was to assess the effects of inulin and fructo-oligosaccharides (FOS) on intestinal microbiota and colitis in HLA-B27 transgenic rats, a...
-
Isomaltodextrin dose-dependently reduces colitis development in HLA-B27 rat colitis model with associated changes to gut microbiota composition and short chain fatty acid production
DownloadFall 2021
Prevalence rates for inflammatory bowel diseases (IBD) worldwide have been drastically increasing over recent decades. IBD is characterized by altered intestinal microbiome (i.e. dysbiosis), described by reduced strict butyrate-producing anaerobes versus increased facultative anaerobes in...